Key result
Electroanatomic mapping enables zero-radiation pacemaker implantation in pregnancy to safely deliver transplacental anti-arrhythmics.
Why the study?
Can electroanatomic mapping be used for zero-fluoroscopy pacemaker implantation in a pregnant woman to allow safe delivery of transplacental anti-arrhythmic medications for fetal SVT?
Case Report (n=2)
Can electroanatomic mapping be used for zero-fluoroscopy pacemaker implantation in a pregnant woman to allow safe delivery of transplacental anti-arrhythmic medications for fetal SVT?
Electroanatomic mapping can be used for zero-fluoroscopy pacemaker implantation in pregnant women, enabling safe administration of transplacental anti-arrhythmic medications for fetal arrhythmias.
No takes yet. Share an insight, caveat, or question.
May enable zero-fluoroscopy pacing in pregnancy to facilitate fetal therapy; hypothesis-generating and requires prospective validation.
Chaudhry‐Waterman et al. (2020) conducted a case report in Maternal high grade atrioventricular block and fetal complex congenital heart disease with supraventricular tachycardia (n=2). Electroanatomic mapping for permanent pacemaker implantation and transplacental anti-arrhythmic medications was evaluated on Successful pacemaker implantation with zero radiation exposure and reduction of fetal arrhythmia burden. Electroanatomic mapping allowed successful permanent pacemaker implantation with zero radiation exposure in a pregnant woman, enabling safe delivery of transplacental anti-arrhythmic medications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: